Lower-face and neck antiaging treatment and prevention using onabotulinumtoxin A: The 2010 multidisciplinary French consensus - part 2

Journal of Cosmetic Dermatology

Volumn 10, Issue 2, 2011, Pages 131-149

  Raspaldo, Herve ^a   Niforos, Francois Rene ^a   Gassia, Veronique ^a   Dallara, Jean Marie ^a   Bellity, Philippe ^a   Baspeyras, Martine ^a   Belhaouari, Lakhdar ^a  

^a Private medical clinic in Cannes ^*  (France)

Author keywords

Botulinum toxin type A; Cosmetic techniques; Face; Onabotulinumtoxin A; Rejuvenation

Indexed keywords

BOTULINUM TOXIN A;

AGING; CONSENSUS; CUTANEOUS PARAMETERS; ESTHETICS; FACE; FACE ASYMMETRY; FACE MALFORMATION; FRANCE; HUMAN; NECK; NOSE RECONSTRUCTION; PRIORITY JOURNAL; QUESTIONNAIRE; REJUVENATION; REVIEW; TREATMENT INDICATION; WRINKLE;

BOTULINUM TOXINS, TYPE A; CHIN; DATA COLLECTION; FRANCE; HUMANS; LIP; NECK; NEUROMUSCULAR AGENTS; NOSE; REJUVENATION; SKIN AGING;

EID: 79958264437     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2011.00560.x     Document Type: Review

References (28)

1. Brandt FS, Boker A. Botulinum toxin for the treatment of neck lines and neck bands. Dermatol Clin 2004; 22: 159-66.
2. Fedok FG. Advances in minimally invasive facial rejuvenation. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 359-68.
3. Fagien S, Raspaldo H. Facial rejuvenation with botulinum neurotoxin: an anatomical and experiential perspective. J Cosmet Laser Ther 2007; 9(Suppl. 1): 23-31.
4. ®: Summary of Product Characteristics. Revised: 09/2009.
5. AFSSAPS. Rapport public d'évaluation: Vistabel 4 unités Allergan/0.1mL, poudre pour solution injectable; 2004.
6. Kaplan SE, Sherris DA, Gassner HG et al. The use of botulinum toxin A in perioral rejuvenation. Facial Plast Surg Clin North Am 2007; 15: 415-21, v-vi.
7. Carruthers JD, Glogau RG, Blitzer A. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies - consensus recommendations. Plast Reconstr Surg 2008; 121: 5S-30S.
8. Aoki KR, Ranoux D, Wissel J. Using translational medicine to understand clinical differences between botulinum toxin formulations. Eur J Neurol 2006; 13(Suppl. 4): 10-9.
9. Cliff SH, Judodihardjo H, Eltringham E. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study. J Cosmet Dermatol 2008; 7: 50-4.
10. Trindade de Almeida AR, Marques E, de Almeida J et al. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg 2007; 33: S37-43.
11. Bassichis BA. Cosmetic use of botulinum toxin in the upper face. Oper Tech Otolaryngol 2007; 18: 248-53.
12. Shetty MK. Guidelines on the use of botulinum toxin type A. Indian J Dermatol Venereol Leprol 2008; 74(Suppl.): S13-22.
13. Sommer B, Bergfeld D, Sattler G. [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine]. J Dtsch Dermatol Ges 2007; 5(Suppl. 1): S1-29.
14. Braccini F, Dohan Ehrenfest DM. [Medical rhinoplasty: rationale for atraumatic nasal modelling using botulinum toxin and fillers]. Rev Laryngol Otol Rhinol 2008; 129: 233-8.
15. Mann DG, Sasaki CT, Fukuda H et al. Dilator naris muscle. Ann Otol Rhinol Laryngol 1977; 86: 362-70.
16. Belhaouari L, Gassia V. Anatomie. In: Beylot C, Michaud T, eds. Anatomie, Arnette edn. France: Wolters Kluwer; 2006: pp. 25-59.
17. Carruthers J, Carruthers A. Botulinum toxin below the eyes. Int Ophthalmol Clin 2005; 45: 133-41.
18. Lowe NJ, Yamauchi P. Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Clin Dermatol 2004; 22: 18-22.
19. Alam M, Dover JS, Klein AW et al. Botulinum a exotoxin for hyperfunctional facial lines: where not to inject. Arch Dermatol 2002; 138: 1180-5.
20. Pena MA, Alam M, Yoo SS. Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg 2007; 26: 26-33.
21. Hur MS, Hu KS, Cho JY et al. Topography and location of the depressor anguli oris muscle with a reference to the mental foramen. Surg Radiol Anat 2008; 30: 403-7.
22. Hwang WS, Hur MS, Hu KS et al. Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin. Angle Orthod 2009; 79: 70-7.
23. Liew S, Dart A. Nonsurgical reshaping of the lower face. Aesthet Surg J 2008; 28: 251-7.
24. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 2005; 6: 141-50.
25. st year of the European Academy of Facial Plastic Surgery; 2008 September 24-28, 2008; Düsseldorf: Medimond S.r.l.
26. Frankel AS, Markarian A. Cosmetic treatments and strategies for the upper face. Facial Plast Surg Clin North Am 2007; 15: 31-9, vi.
27. Jost G, Lamouche G. SMAS in rhytidectomy. Aesthetic Plast Surg 1982; 6: 69-74.
28. Mitz V, Peyronie M. The Superficial Musculo-Aponeurotic System (SMAS) in the parotid and cheek area. Plast Reconstr Surg 1976; 58: 80-8.